Metcela is a series c plus startup based in Japan. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Metcela is a clinical-stage biotechnology company developing autologous cell therapies (VCFs) targeting serious cardiovascular diseases, particularly heart failure.
Stage
series-c-plus
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky